Interleukin 2 gene therapy of surgical minimal residual tumour disease: characterization of cytolytic effector cells from tumour progressors and regressors.

Source:http://linkedlifedata.com/resource/pubmed/id/10732718

Download in:

View as

General Info

PMID
10732718